{"transactions":[{"id":2939191,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-17T23:58:55.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on September 9, 2016 and vested over four years with 25% of the shares having vested on August 22, 2017, and the remaining 75% of the shares having vested in equal monthly installments thereafter through August 22, 2020."}],"balance_after":145000,"derivative":{"exercise_price":16.51,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-012070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020012070/edgar.xml","form_type":"4"}},{"id":2939190,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-17T23:58:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":200,"price":64.39,"value":12878.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":24907,"source":{"system":"sec-edgar","filing":"0001179110-20-012070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020012070/edgar.xml","form_type":"4"}},{"id":2939189,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-17T23:58:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":4024,"price":63.84,"value":256892.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $63.24 to $64.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25107,"source":{"system":"sec-edgar","filing":"0001179110-20-012070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020012070/edgar.xml","form_type":"4"}},{"id":2939188,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-17T23:58:55.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":5776,"price":62.74,"value":362386.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $62.18 to $63.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29131,"source":{"system":"sec-edgar","filing":"0001179110-20-012070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020012070/edgar.xml","form_type":"4"}},{"id":2939187,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-17T23:58:55.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":10000,"price":16.51,"value":165100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":34907,"source":{"system":"sec-edgar","filing":"0001179110-20-012070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020012070/edgar.xml","form_type":"4"}},{"id":2948049,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-11T21:14:35.000Z","date":"2020-12-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on September 9, 2016 and vested over four years with 25% of the shares having vested on August 22, 2017, and the remaining 75% of the shares having vested in equal monthly installments thereafter through August 22, 2020."}],"balance_after":155000,"derivative":{"exercise_price":16.51,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-011830","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020011830/edgar.xml","form_type":"4"}},{"id":2948048,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-11T21:14:35.000Z","date":"2020-12-09","kind":"sale","acquired":false,"shares":10000,"price":45,"value":450000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":24907,"source":{"system":"sec-edgar","filing":"0001179110-20-011830","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020011830/edgar.xml","form_type":"4"}},{"id":2948047,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-11T21:14:35.000Z","date":"2020-12-09","kind":"exercise","acquired":true,"shares":10000,"price":16.51,"value":165100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":34907,"source":{"system":"sec-edgar","filing":"0001179110-20-011830","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020011830/edgar.xml","form_type":"4"}},{"id":2952992,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-08T21:12:09.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 9, 2016 and vested over four years with 25% of the shares having vested on August 22, 2017, and the remaining 75% of the shares having vested in equal monthly installments thereafter through August 22, 2020."}],"balance_after":165000,"derivative":{"exercise_price":16.51,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-20-011752","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020011752/edgar.xml","form_type":"4"}},{"id":2952991,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:12:09.000Z","date":"2020-12-07","kind":"sale","acquired":false,"shares":20000,"price":40.02,"value":800400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $40.00 to $40.06. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24907,"source":{"system":"sec-edgar","filing":"0001179110-20-011752","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020011752/edgar.xml","form_type":"4"}},{"id":2952990,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:12:09.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":20000,"price":16.51,"value":330200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":44907,"source":{"system":"sec-edgar","filing":"0001179110-20-011752","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020011752/edgar.xml","form_type":"4"}},{"id":2985945,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-10T21:13:43.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":228,"price":31.21,"value":7115.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2020. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":24907,"source":{"system":"sec-edgar","filing":"0001179110-20-010963","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020010963/edgar.xml","form_type":"4"}},{"id":3004839,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-10-16T20:38:36.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":3000,"price":31.39,"value":94170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.88 to $31.77. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25135,"source":{"system":"sec-edgar","filing":"0001179110-20-010507","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020010507/edgar.xml","form_type":"4"}},{"id":3051858,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-19T20:44:16.000Z","date":"2020-08-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 9, 2016 and is scheduled to vest over four years with 25% of the shares having vested on August 22, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through August 22, 2020."}],"balance_after":185000,"derivative":{"exercise_price":16.51,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-009170","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/edgar.xml","form_type":"4"}},{"id":3051857,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-19T20:44:16.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":10000,"price":35.29,"value":352900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.60. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28135,"source":{"system":"sec-edgar","filing":"0001179110-20-009170","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/edgar.xml","form_type":"4"}},{"id":3051856,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-19T20:44:16.000Z","date":"2020-08-17","kind":"exercise","acquired":true,"shares":10000,"price":16.51,"value":165100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":38135,"source":{"system":"sec-edgar","filing":"0001179110-20-009170","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/edgar.xml","form_type":"4"}},{"id":3063064,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-10T20:24:09.000Z","date":"2020-08-06","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on September 9, 2016 and is scheduled to vest over four years with 25% of the shares having vested on August 22, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through August 22, 2020."}],"balance_after":195000,"derivative":{"exercise_price":16.51,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-008833","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/edgar.xml","form_type":"4"}},{"id":3063063,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:09.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":238,"price":34.99,"value":8327.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2020. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $34.69 to $35.00. The price reported above reflects the weighted average sale price. The Reporting Person herebyundertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28135,"source":{"system":"sec-edgar","filing":"0001179110-20-008833","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/edgar.xml","form_type":"4"}},{"id":3063062,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:09.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":10000,"price":37.47,"value":374700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":28373,"source":{"system":"sec-edgar","filing":"0001179110-20-008833","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/edgar.xml","form_type":"4"}},{"id":3063061,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:09.000Z","date":"2020-08-06","kind":"exercise","acquired":true,"shares":10000,"price":16.51,"value":165100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":38373,"source":{"system":"sec-edgar","filing":"0001179110-20-008833","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/edgar.xml","form_type":"4"}},{"id":3080011,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-17T21:32:50.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":3000,"price":32.22,"value":96660.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020."}],"balance_after":28373,"source":{"system":"sec-edgar","filing":"0001179110-20-008367","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020008367/edgar.xml","form_type":"4"}},{"id":3155958,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-08T20:17:40.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":151,"price":25.28,"value":3817.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represent the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 6, 2020. The sales do not represent a discretionary trade by the Reporting Person."}],"balance_after":31373,"source":{"system":"sec-edgar","filing":"0001179110-20-005605","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020005605/edgar.xml","form_type":"4"}},{"id":3281526,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-10T21:34:06.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":69556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 6, 2020 and is scheduled to vest over four years in equal monthly installments beginning on March 6, 2020 through February 6, 2024."}],"balance_after":69556,"derivative":{"exercise_price":28.05,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":69556},"source":{"system":"sec-edgar","filing":"0001179110-20-001370","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/edgar.xml","form_type":"4"}},{"id":3281525,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-10T21:34:06.000Z","date":"2020-02-07","kind":"sale","acquired":false,"shares":622,"price":26.95,"value":16762.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represent the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 6, 2020. The sales do not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $26.42 to $26.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31524,"source":{"system":"sec-edgar","filing":"0001179110-20-001370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/edgar.xml","form_type":"4"}},{"id":3281524,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-10T21:34:06.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":11593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on February 6, 2021 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2024."}],"balance_after":32146,"source":{"system":"sec-edgar","filing":"0001179110-20-001370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/edgar.xml","form_type":"4"}},{"id":3290458,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-04T22:24:52.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":17977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, which vested in full on January 31, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock unit award vested in full on January 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock unit award vested in full on January 31, 2020."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":17977},"source":{"system":"sec-edgar","filing":"0001179110-20-001026","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/edgar.xml","form_type":"4"}},{"id":3290457,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-04T22:24:52.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":5549,"price":26.5431,"value":147287.6619,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to an durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represent the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on January 31, 2020. The sales do not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Such amount includes common stock received by the Reporting Person in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, which is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023, which was previously reported on Table II of a Form 4 filed by the Reporting Person with the SEC on February 8, 2019."}],"balance_after":20553,"source":{"system":"sec-edgar","filing":"0001179110-20-001026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/edgar.xml","form_type":"4"}},{"id":3290456,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-04T22:24:52.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":17977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, which vested in full on January 31, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Such amount includes common stock received by the Reporting Person in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, which is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023, which was previously reported on Table II of a Form 4 filed by the Reporting Person with the SEC on February 8, 2019."}],"balance_after":26102,"source":{"system":"sec-edgar","filing":"0001179110-20-001026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/edgar.xml","form_type":"4"}},{"id":3667548,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-09T00:37:29.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest."}],"balance_after":8125,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001179110-19-001684","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019001684/edgar.xml","form_type":"4"}},{"id":3667547,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-09T00:37:29.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 6, 2019 and is scheduled to vest over four years in equal monthly installments beginning on February 6, 2019 through February 6, 2023."}],"balance_after":48750,"derivative":{"exercise_price":21.1,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":48750},"source":{"system":"sec-edgar","filing":"0001179110-19-001684","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019001684/edgar.xml","form_type":"4"}},{"id":3676777,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-04T22:29:16.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":17977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award is scheduled to vest in its entirety on January 31, 2020, subject to acceleration in specified circumstances. Vested shares will be delivered to the Reporting Person on January 31, 2020."}],"balance_after":17977,"derivative":{"underlying":"Common Stock","underlying_shares":17977},"source":{"system":"sec-edgar","filing":"0001179110-19-001235","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911019001235/edgar.xml","form_type":"4"}},{"id":3892016,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-15T20:16:56.000Z","date":"2018-06-13","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 23, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 9, 2016 and is scheduled to vest over four years with 25% of the shares having vested on August 22, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through August 22, 2020."}],"balance_after":205000,"derivative":{"exercise_price":16.51,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-18-008611","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008611/edgar.xml","form_type":"4"}},{"id":3892015,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-06-15T20:16:56.000Z","date":"2018-06-13","kind":"sale","acquired":false,"shares":10000,"price":35.98,"value":359800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.62 to $36.60. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-008611","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008611/edgar.xml","form_type":"4"}},{"id":3892014,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-06-15T20:16:56.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":10000,"price":16.51,"value":165100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 23, 2018."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001179110-18-008611","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018008611/edgar.xml","form_type":"4"}},{"id":3916645,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-25T20:31:40.000Z","date":"2018-05-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 23, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on September 9, 2016 and is scheduled to vest over four years with 25% of the shares having vested on August 22, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through August 22, 2020."}],"balance_after":215000,"derivative":{"exercise_price":16.51,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-18-007566","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018007566/edgar.xml","form_type":"4"}},{"id":3916644,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-05-25T20:31:40.000Z","date":"2018-05-23","kind":"sale","acquired":false,"shares":10000,"price":35,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 23, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-007566","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018007566/edgar.xml","form_type":"4"}},{"id":3916643,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-05-25T20:31:40.000Z","date":"2018-05-23","kind":"exercise","acquired":true,"shares":10000,"price":16.51,"value":165100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 23, 2018."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001179110-18-007566","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018007566/edgar.xml","form_type":"4"}},{"id":4068078,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-09T22:23:04.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":71500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 7, 2018 and is scheduled to vest over four years in equal monthly installments beginning on February 7, 2018 through February 7, 2022."}],"balance_after":71500,"derivative":{"exercise_price":36.67,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":71500},"source":{"system":"sec-edgar","filing":"0001179110-18-001907","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911018001907/edgar.xml","form_type":"4"}},{"id":4402316,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-03T18:14:38.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 1, 2017 and is scheduled to vest over four years in equal monthly installments beginning on March 1, 2017 through March 1, 2021."}],"balance_after":45000,"derivative":{"exercise_price":24.6,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001179110-17-003788","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911017003788/edgar.xml","form_type":"4"}},{"id":4603904,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":144555,"kind":"person","name":"Albright Charles","position":1,"cik":"0001682323","reported_name":"Albright Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-13T21:06:16.000Z","date":"2016-09-09","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 9, 2016 and is scheduled to vest over four years with 25% of the shares scheduled to vest on August 22, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through August 22, 2020."}],"balance_after":225000,"derivative":{"exercise_price":16.51,"expiration_date":"2026-09-08","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001179110-16-029608","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911016029608/edgar.xml","form_type":"4"}}]}